Nexgel (NXGL) Long-Term Deferred Tax (2021 - 2022)
Nexgel (NXGL) posted Long-Term Deferred Tax of $4.1 million for Q4 2022, up 23.48% on a QoQ basis from $3.3 million in Q4 2021, and up 23.48% year-over-year from $3.3 million in Q4 2021.
Nexgel (NXGL) Long-Term Deferred Tax (2021 - 2022) Analysis & Trends
Nexgel's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $4.1 million for Q4 2022.
- Quarterly Long-Term Deferred Tax rose 23.48% year-over-year to $4.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $4.1 million (up 23.48% YoY) and the FY2022 annual result came in at $4.1 million, up 23.48% from the prior year.
- Long-Term Deferred Tax was $4.1 million for Q4 2022 at Nexgel, up from $3.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $4.1 million in Q4 2022 and bottomed at $3.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 3.33 Mn |